Dr. Jagadeesh Kumar Kalavakunta, MD

Dr. Kalavakunta practices at Bariatric Center - Ascension Borgess Bariatric Center - HOPD in Kalamazoo, Michigan.

Dr. Kalavakunta's NPI, 1457510505, was assigned on June 4, 2008. Dr. Kalavakunta holds Michigan license 4301091982.

Dr. Kalavakunta's primary practice is Bariatric Center - Ascension Borgess Bariatric Center - HOPD, at 1717 Shaffer St, Kalamazoo, MI 49048.

Dr. Kalavakunta's primary practice is Bariatric Center - Ascension Borgess Bariatric Center - HOPD in Kalamazoo, Michigan. Dr. Kalavakunta is also affiliated with Beacon Kalamazoo. The medical group on file is Beacon Portage Family Medicine. Dmand AI also links Dr. Kalavakunta to 5 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account. Dr. Kalavakunta's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalavakunta practices, 9 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kalavakunta's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Kalavakunta is licensed in Michigan.

CMS data shows 2,978 Medicare services from Dr. Kalavakunta across 33 procedure codes in 2024, for 1,181 Medicare patients. Medicare paid $172,578 for them.

CMS counts 1,181 Medicare patients who saw Dr. Kalavakunta in 2024. The largest group is 65 to 74, with 448 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kalavakunta's median patient age at 74, with 50% women.

In 2024, Dr. Kalavakunta wrote 7,994 Medicare Part D claims for 1,123 patients. 86% of them were for generic drugs. CMS names the drug for 7,777 of them, across 62 drugs with 11 or more claims each, at $1,359,152 in total drug cost. In 2023, CMS named 6,899 claims across 49 drugs.

Dr. Kalavakunta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kalavakunta as offering telehealth. CMS counts 57 procedures of coronary angioplasty and stenting by Dr. Kalavakunta, more than 87% of the clinicians it reports for that procedure.

CMS Open Payments shows 511 general payments to Dr. Kalavakunta from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Boston Scientific Corporation paid the most, $6,980.